BRIO promotes the development of cutting edge technologies and know-how capable of supporting translational research projects in Oncology. Through the BRIO label, these platforms will benefit from special financial schemes supporting their use from BRIO participating group and specific actions aimed at further developing the quality of their offer and impact on cancer research and patients’ care. Please browse through the list of available BRIO platforms or contact us for further information